Similar articles for PMID: 25227304

Year	Number of Results
1825	1
1883	1
1901	1
1910	1
1928	1
1962	1
1995	1
1999	1
2002	1
2003	1
2004	1
2005	3
2006	3
2007	3
2008	5
2009	2
2010	4
2011	6
2012	5
2013	13
2014	15
2015	11
2016	1
2017	2
2018	1
2019	2
2020	1
2021	1
2023	1
2024	0

1

Nutrition, gut microbiota and immunity: therapeutic targets for IBD. Concluding remarks.

Lewis JD, Ruemmele FM, Wu GD. Lewis JD, et al. Nestle Nutr Inst Workshop Ser. 2014;79:161-2. doi: 10.1159/000360721. Epub 2014 Sep 5. Nestle Nutr Inst Workshop Ser. 2014. PMID: 25227304 No abstract available.

2

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.

Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L, Cammarota G, Gaetani E, Sgambato A, Gasbarrini A. Scaldaferri F, et al. Biomed Res Int. 2013;2013:435268. doi: 10.1155/2013/435268. Epub 2013 Aug 7. Biomed Res Int. 2013. PMID: 23991417 Free PMC article. Review.

3

Antibiotics, probiotics and prebiotics in IBD.

Bernstein CN. Bernstein CN. Nestle Nutr Inst Workshop Ser. 2014;79:83-100. doi: 10.1159/000360713. Epub 2014 Sep 5. Nestle Nutr Inst Workshop Ser. 2014. PMID: 25227297 Review.

4

Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?

Verbeke KA, Boesmans L, Boets E. Verbeke KA, et al. Proc Nutr Soc. 2014 Nov;73(4):490-7. doi: 10.1017/S0029665114000639. Epub 2014 Jun 27. Proc Nutr Soc. 2014. PMID: 24969143

5

The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.

Cammarota G, Ianiro G, Cianci R, Bibbò S, Gasbarrini A, Currò D. Cammarota G, et al. Pharmacol Ther. 2015 May;149:191-212. doi: 10.1016/j.pharmthera.2014.12.006. Epub 2015 Jan 3. Pharmacol Ther. 2015. PMID: 25561343 Review.

6

Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights.

Sinagra E, Tomasello G, Cappello F, Leone A, Cottone M, Bellavia M, Rossi F, Facella T, Damiani P, Zeenny MN, Damiani F, Abruzzo A, Damiano G, Palumbo VD, Cocchi M, Jurjus A, Spinelli G, Lo Monte AI, Raimondo D. Sinagra E, et al. J Biol Regul Homeost Agents. 2013 Oct-Dec;27(4):919-33. J Biol Regul Homeost Agents. 2013. PMID: 24382173 Review.

7

Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.

Schulberg J, De Cruz P. Schulberg J, et al. Intern Med J. 2016 Mar;46(3):266-73. doi: 10.1111/imj.13003. Intern Med J. 2016. PMID: 26968595 Review.

8

Probiotics, prebiotics and amelioration of diseases.

Tsai YL, Lin TL, Chang CJ, Wu TR, Lai WF, Lu CC, Lai HC. Tsai YL, et al. J Biomed Sci. 2019 Jan 4;26(1):3. doi: 10.1186/s12929-018-0493-6. J Biomed Sci. 2019. PMID: 30609922 Free PMC article. Review.

9

Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.

Yu CG, Huang Q. Yu CG, et al. J Dig Dis. 2013 Oct;14(10):513-7. doi: 10.1111/1751-2980.12087. J Dig Dis. 2013. PMID: 23848393 Review.

10

Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.

Kerman DH, Deshpande AR. Kerman DH, et al. Postgrad Med. 2014 Jul;126(4):7-19. doi: 10.3810/pgm.2014.07.2779. Postgrad Med. 2014. PMID: 25141239 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

84 results

Results by year